BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17945187)

  • 1. Inter-conversion of neuregulin2 full and partial agonists for ErbB4.
    Wilson KJ; Mill CP; Cameron EM; Hobbs SS; Hammer RP; Riese DJ
    Biochem Biophys Res Commun; 2007 Dec; 364(2):351-7. PubMed ID: 17945187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
    Wilson KJ; Mill CP; Gallo RM; Cameron EM; VanBrocklin H; Settleman J; Riese DJ
    Biochem J; 2012 Apr; 443(1):133-44. PubMed ID: 22216880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase.
    Hobbs SS; Cameron EM; Hammer RP; Le AT; Gallo RM; Blommel EN; Coffing SL; Chang H; Riese DJ
    Oncogene; 2004 Jan; 23(4):883-93. PubMed ID: 14661053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*.
    Hobbs SS; Gallo RM; Riese DJ
    Growth Factors; 2005 Dec; 23(4):273-83. PubMed ID: 16338790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics.
    Cullum RL; Lucas LM; Senfeld JI; Piazza JT; Neel LT; Whig K; Zhai L; Harris MH; Rael CC; Taylor DC; Cook LJ; Kaufmann DP; Mill CP; Jacobi MA; Smith FT; Suto M; Bostwick R; Gupta RB; David AE; Riese Ii DJ
    PLoS One; 2020; 15(12):e0243901. PubMed ID: 33378376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive recombinant neuregulin-1, -2, and -3 expressed in Escherichia coli.
    Mautino B; Dalla Costa L; Gambarotta G; Perroteau I; Fasolo A; Dati C
    Protein Expr Purif; 2004 May; 35(1):25-31. PubMed ID: 15039062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation.
    Hobbs SS; Coffing SL; Le AT; Cameron EM; Williams EE; Andrew M; Blommel EN; Hammer RP; Chang H; Riese DJ
    Oncogene; 2002 Dec; 21(55):8442-52. PubMed ID: 12466964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4.
    Zhang D; Sliwkowski MX; Mark M; Frantz G; Akita R; Sun Y; Hillan K; Crowley C; Brush J; Godowski PJ
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9562-7. PubMed ID: 9275162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTAKalpha and beta isoforms stimulate breast tumor cell growth by means of different receptor combinations.
    Nakano N; Higashiyama S; Kajihara K; Endo T; Ishiguro H; Yamada K; Nagatsu T; Taniguchi N
    J Biochem; 2000 May; 127(5):925-30. PubMed ID: 10788804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.
    Riese DJ; Komurasaki T; Plowman GD; Stern DF
    J Biol Chem; 1998 May; 273(18):11288-94. PubMed ID: 9556621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes.
    Zhao YY; Feron O; Dessy C; Han X; Marchionni MA; Kelly RA
    Circ Res; 1999 Jun; 84(12):1380-7. PubMed ID: 10381889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation.
    Gilmore JL; Riese DJ
    Oncol Res; 2004; 14(11-12):589-602. PubMed ID: 15667000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand discrimination in signaling through an ErbB4 receptor homodimer.
    Sweeney C; Lai C; Riese DJ; Diamonti AJ; Cantley LC; Carraway KL
    J Biol Chem; 2000 Jun; 275(26):19803-7. PubMed ID: 10867024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines.
    Pitfield SE; Bryant I; Penington DJ; Park G; Riese DJ
    Oncol Res; 2006; 16(4):179-93. PubMed ID: 17120616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death or survival promoted by alternative isoforms of ErbB4.
    Sundvall M; Veikkolainen V; Kurppa K; Salah Z; Tvorogov D; van Zoelen EJ; Aqeilan R; Elenius K
    Mol Biol Cell; 2010 Dec; 21(23):4275-86. PubMed ID: 20943952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2.
    Crovello CS; Lai C; Cantley LC; Carraway KL
    J Biol Chem; 1998 Oct; 273(41):26954-61. PubMed ID: 9756944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration.
    Gambarotta G; Garzotto D; Destro E; Mautino B; Giampietro C; Cutrupi S; Dati C; Cattaneo E; Fasolo A; Perroteau I
    J Biol Chem; 2004 Nov; 279(47):48808-16. PubMed ID: 15355992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.
    Kainulainen V; Sundvall M; Määttä JA; Santiestevan E; Klagsbrun M; Elenius K
    J Biol Chem; 2000 Mar; 275(12):8641-9. PubMed ID: 10722704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.